Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Karine Andrieux"'
Nanomedicine as a potential approach to empower the new strategies for the treatment of preeclampsia
Autor:
Sophie Gil, Lucie Valero, Karine Andrieux, Nathalie Mignet, Thierry Fournier, Edouard Lecarpentier, Vassilis Tsatsaris, Khair Alhareth
Publikováno v:
Drug Discovery Today Biosilico
Drug Discovery Today Biosilico, Elsevier, 2018, 23 (5), pp.1099-1107. ⟨10.1016/j.drudis.2018.01.048⟩
Drug Discovery Today Biosilico, 2018, 23 (5), pp.1099-1107. ⟨10.1016/j.drudis.2018.01.048⟩
Drug Discovery Today Biosilico, Elsevier, 2018, 23 (5), pp.1099-1107. ⟨10.1016/j.drudis.2018.01.048⟩
Drug Discovery Today Biosilico, 2018, 23 (5), pp.1099-1107. ⟨10.1016/j.drudis.2018.01.048⟩
International audience; Preeclampsia is a serious pregnancy disorder characterized by the onset of high blood pressure and proteinuria. Although the understanding of the disease is increasing, it remains without treatment, other than the delivery of
Autor:
Sébastien Goutal, Xavier Declèves, Karine Andrieux, Fabien Caillé, Oliver Langer, Christine Coulon, Sylvain Auvity, Philippe Gervais, Salvatore Cisternino, Nicolas Tournier
Publikováno v:
Drug Delivery and Translational Research
Drug Delivery and Translational Research, Springer, 2018, 8 (3), pp.536-542. ⟨10.1007/s13346-017-0472-6⟩
Drug Delivery and Translational Research, 2018, 8 (3), pp.536-542. ⟨10.1007/s13346-017-0472-6⟩
Drug Delivery and Translational Research, Springer, 2018, 8 (3), pp.536-542. ⟨10.1007/s13346-017-0472-6⟩
Drug Delivery and Translational Research, 2018, 8 (3), pp.536-542. ⟨10.1007/s13346-017-0472-6⟩
International audience; Elacridar (GF120918) is a highly potent inhibitor of both P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2), the main efflux transporters expressed at the blood-brain barrier (BBB). Elacridar shows very low a
Autor:
Sophie Gil, Christelle Simasotchi, Karine Andrieux, Khair Alhareth, Thierry Fournier, Lucie Valero, Nathalie Mignet, Daniel Scherman, Caroline Roques
Publikováno v:
International Journal of Pharmaceutics
International Journal of Pharmaceutics, Elsevier, 2017, 532 (2), pp.729-737. ⟨10.1016/j.ijpharm.2017.07.076⟩
International Journal of Pharmaceutics, Elsevier, 2017, 532 (2), pp.729-737. ⟨10.1016/j.ijpharm.2017.07.076⟩
Uptake and passage of nanocarriers through the placenta are critical information to develop new therapeutic approaches during pregnancy. In order to assess nanocarriers transplacental passage and penetration into the placenta, we studied and optimize
Publikováno v:
Pharmaceutics
Volume 12
Issue 11
Pharmaceutics, MDPI, 2020, 12 (11), ⟨10.3390/pharmaceutics12111060⟩
Pharmaceutics, 2020, 12 (11), ⟨10.3390/pharmaceutics12111060⟩
Pharmaceutics, Vol 12, Iss 1060, p 1060 (2020)
Volume 12
Issue 11
Pharmaceutics, MDPI, 2020, 12 (11), ⟨10.3390/pharmaceutics12111060⟩
Pharmaceutics, 2020, 12 (11), ⟨10.3390/pharmaceutics12111060⟩
Pharmaceutics, Vol 12, Iss 1060, p 1060 (2020)
Rapamycin has been used topically to treat facial angiofibromas associated with tuberous sclerosis for more than a decade. In the absence of a commercial form, a large number of formulations have been clinically tested. However, given the great heter
Autor:
Lucie Valero, Jeanne Leblond, Thierry Fournier, Caroline Roques, Danielle Campiol Arruda, Virginie Escriou, Karine Andrieux, Nathalie Mignet, Audrey Chissey, Khair Alhareth, Warren Viricel, Jenifer Espinoza Romero, Hélène Dhotel
Publikováno v:
Molecules
Molecules, MDPI, 2018, 23 (5), pp.1085. ⟨10.3390/molecules23051085⟩
Molecules, 2018, 23 (5), pp.1085. ⟨10.3390/molecules23051085⟩
Molecules, Vol 23, Iss 5, p 1085 (2018)
Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry
Molecules, MDPI, 2018, 23 (5), pp.1085. ⟨10.3390/molecules23051085⟩
Molecules, 2018, 23 (5), pp.1085. ⟨10.3390/molecules23051085⟩
Molecules, Vol 23, Iss 5, p 1085 (2018)
Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry
Nanomedicine as a therapeutic approach for pregnancy-related diseases could offer improved treatments for the mother while avoiding side effects for the fetus. In this study, we evaluated the potential of liposomes as carriers for small interfering R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89f75e5defa3337d0d0847f0787b4589
https://hal.archives-ouvertes.fr/hal-02123142
https://hal.archives-ouvertes.fr/hal-02123142
Autor:
Thierry Fournier, Louise Fliedel, Karine Andrieux, Khair Alhareth, Nathalie Mignet, Khaled Elhady Mohamed, Lucie Valero, Sophie Gil, Caroline Roques
Publikováno v:
International Journal of Pharmaceutics. 567:118479
Controlled distribution of a drug by its association to a nanocarrier is a promising approach for the treatment of pregnancy disorders such as preeclampsia. For this application, tracking both the nanocarrier and the drug is necessary to ensure the s
Autor:
Karine Andrieux, Fawzia Bekkara-Aounallah, Christine Rogez-Kreuz, Ruxandra Gref, Patrick Couvreur, Sébastien Argote, Joachim Caron, Rym Skanji, Rahima Yousfi, Hervé Hillaireau, Laurent Bauduin, Nathalie Dereuddre-Bosquet, Didier Desmaële, Bernard Rousseau, Sinda Lepêtre, Pascal Clayette
Publikováno v:
Biomaterials. 34:4831-4838
Due to their hydrophilic nature, most nucleoside reverse transcriptase inhibitors (NRTIs) display a variable bioavailability after oral administration and a poor control over their biodistribution, thus hampering their access to HIV sanctuaries. The
Autor:
Julien Nicolas, Alice Panariti, Silvia Sesana, Patrick Couvreur, Karine Andrieux, Massimo Masserini, Davide Brambilla, Francesca Re, Antonina Orlando, Emanuela Cazzaniga, Ilaria Rivolta
Publikováno v:
International Journal of Nanomedicine, Vol 2013, Iss default, Pp 1335-1347 (2013)
International Journal of Nanomedicine
International Journal of Nanomedicine
Antonina Orlando,1 Francesca Re,1 Silvia Sesana,1 Ilaria Rivolta,1 Alice Panariti,1 Davide Brambilla,2 Julien Nicolas,2 Patrick Couvreur,2 Karine Andrieux,2 Massimo Masserini,1 Emanuela Cazzaniga1 1Department of Health Sciences, University of Milano-
Autor:
Karine Andrieux, S. Hossein Hashemi, Lin-Ping Wu, Julien Nicolas, S. Moein Moghimi, Davide Brambilla, Patrick Couvreur, Benjamin Le Droumaguet
Publikováno v:
Nanomedicine: Nanotechnology, Biology and Medicine
Alzheimer's disease (AD) represents the most common form of dementia worldwide, affecting more than 35 million people. Advances in nanotechnology are beginning to exert a significant impact in neurology. These approaches, which are often based on the
Autor:
Niko Hildebrandt, Oya Tagit, Didier Desmaële, Patrick Couvreur, Valérie Nicolas, Dunja Sobot, Kevin Braeckmans, Sinda Lepetre-Mouelhi, Julie Mougin, Stefaan C. De Smedt, Alice Gaudin, Thomas Martens, Karine Andrieux
Publikováno v:
Chemistry of Materials
Chemistry of Materials, 2015, 27 (10), pp.3636-3647. ⟨10.1021/acs.chemmater.5b00267⟩
Chemistry of Materials, American Chemical Society, 2015, 27 (10), pp.3636-3647. ⟨10.1021/acs.chemmater.5b00267⟩
Chemistry of Materials, 2015, 27 (10), pp.3636-3647. ⟨10.1021/acs.chemmater.5b00267⟩
Chemistry of Materials, American Chemical Society, 2015, 27 (10), pp.3636-3647. ⟨10.1021/acs.chemmater.5b00267⟩
Drug delivery to the brain is one of the major challenges in the treatment of cerebral diseases and implies extensive understanding of nanomedicine transcytosis pathways across the blood–brain barr...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac5469d2579cea4afd3225dcc5554527
https://hal.science/hal-02399979
https://hal.science/hal-02399979